BACKGROUND: Chronic kidney disease (CKD) leads to end-stage renal disease and is a growing epidemic throughout the world. In the United States, African Americans have an incidence of end-stage renal disease 4 times that of whites. STUDY DESIGN: Cross-sectional to examine the prevalence and awareness of CKD in African Americans. SETTING & PARTICIPANTS: Observational cohort in the Jackson Heart Study (JHS). PREDICTOR: CKD was defined as an estimated glomerular filtration rate less than 60 mL/min/1.73 m(2), the presence of albuminuria, or dialysis therapy. OUTCOMES & MEASUREMENTS: Data from the JHS were analyzed. Medical history, including disease awareness and drug therapy, anthropometric measurements, and serum and urine samples, were obtained from JHS participants at the baseline visit. Associations between CKD prevalence and awareness and selected demographic, socioeconomic, health care access, and disease status parameters were assessed by using logistic regression models. RESULTS: The prevalence of CKD in the JHS was 20%; CKD awareness was only 15.8%. Older participants had a greater prevalence, but also were more aware of CKD. Hypertension, diabetes, cardiovascular disease, hypercholesterolemia, hypertriglyceridemia, increasing age and waist circumference, and being single or less physically active were associated with CKD. Only advancing CKD stage was associated with awareness. LIMITATIONS: Cross-sectional assessment, single urine measurement. CONCLUSIONS: The JHS has a high prevalence and low awareness of CKD, especially in those with less severe disease status. This emphasizes the need for earlier diagnosis and increased education of health care providers and the general population.
BACKGROUND:Chronic kidney disease (CKD) leads to end-stage renal disease and is a growing epidemic throughout the world. In the United States, African Americans have an incidence of end-stage renal disease 4 times that of whites. STUDY DESIGN: Cross-sectional to examine the prevalence and awareness of CKD in African Americans. SETTING & PARTICIPANTS: Observational cohort in the Jackson Heart Study (JHS). PREDICTOR: CKD was defined as an estimated glomerular filtration rate less than 60 mL/min/1.73 m(2), the presence of albuminuria, or dialysis therapy. OUTCOMES & MEASUREMENTS: Data from the JHS were analyzed. Medical history, including disease awareness and drug therapy, anthropometric measurements, and serum and urine samples, were obtained from JHS participants at the baseline visit. Associations between CKD prevalence and awareness and selected demographic, socioeconomic, health care access, and disease status parameters were assessed by using logistic regression models. RESULTS: The prevalence of CKD in the JHS was 20%; CKD awareness was only 15.8%. Older participants had a greater prevalence, but also were more aware of CKD. Hypertension, diabetes, cardiovascular disease, hypercholesterolemia, hypertriglyceridemia, increasing age and waist circumference, and being single or less physically active were associated with CKD. Only advancing CKD stage was associated with awareness. LIMITATIONS: Cross-sectional assessment, single urine measurement. CONCLUSIONS: The JHS has a high prevalence and low awareness of CKD, especially in those with less severe disease status. This emphasizes the need for earlier diagnosis and increased education of health care providers and the general population.
Authors: Sonja R Fuqua; Sharon B Wyatt; Michael E Andrew; Daniel F Sarpong; Frances R Henderson; Margie F Cunningham; Herman A Taylor Journal: Ethn Dis Date: 2005 Impact factor: 1.847
Authors: James G Wilson; Charles N Rotimi; Lynette Ekunwe; Charmaine D M Royal; Mary E Crump; Sharon B Wyatt; Michael W Steffes; Adebowale Adeyemo; Jie Zhou; Herman A Taylor; Cashell Jaquish Journal: Ethn Dis Date: 2005 Impact factor: 1.847
Authors: Bruce A Perkins; Linda H Ficociello; Betsy E Ostrander; Kristen H Silva; Janice Weinberg; James H Warram; Andrzej S Krolewski Journal: J Am Soc Nephrol Date: 2007-02-28 Impact factor: 10.121
Authors: John H Dirks; Dick de Zeeuw; Sanjay K Agarwal; Robert C Atkins; Ricardo Correa-Rotter; Giuseppe D'Amico; Peter H Bennett; Meguid El Nahas; Raul Herrera Valdes; Dan Kaseje; Ivor J Katz; Sarala Naicker; Bernardo Rodriguez-Iturbe; Arrigo Schieppati; Faissal Shaheen; Chitr Sitthi-Amorn; Kim Solez; Giancarlo Viberti; Giuseppe Remuzzi; Jan J Weening Journal: Kidney Int Suppl Date: 2005-09 Impact factor: 10.545
Authors: Dick de Zeeuw; Giuseppe Remuzzi; Hans-Henrik Parving; William F Keane; Zhongxin Zhang; Shahnaz Shahinfar; Steve Snapinn; Mark E Cooper; William E Mitch; Barry M Brenner Journal: Circulation Date: 2004-08-09 Impact factor: 29.690
Authors: Ian H de Boer; Brad C Astor; Holly Kramer; Walter Palmas; Stephen L Seliger; Michael G Shlipak; David S Siscovick; Michael Y Tsai; Bryan Kestenbaum Journal: Clin J Am Soc Nephrol Date: 2007-12-05 Impact factor: 8.237
Authors: Marino A Bruce; Bettina M Beech; Errol D Crook; Mario Sims; Sharon B Wyatt; Michael F Flessner; Herman A Taylor; David R Williams; Ermeg L Akylbekova; T Alp Ikizler Journal: Am J Kidney Dis Date: 2010-04-08 Impact factor: 8.860
Authors: Jiaqi Hu; D Alan Nelson; Patricia A Deuster; Eric S Marks; Francis G O'Connor; Lianne M Kurina Journal: Br J Haematol Date: 2019-03-11 Impact factor: 6.998
Authors: Casey M Rebholz; Jane L Harman; Morgan E Grams; Adolfo Correa; Daichi Shimbo; Josef Coresh; Bessie A Young Journal: J Am Soc Nephrol Date: 2017-07-11 Impact factor: 10.121
Authors: Marino A Bruce; Bettina M Beech; Errol D Crook; Mario Sims; Derek M Griffith; Sean L Simpson; Jamy Ard; Keith C Norris Journal: J Investig Med Date: 2013-04 Impact factor: 2.895
Authors: Ervin R Fox; Emelia J Benjamin; Daniel F Sarpong; Harsha Nagarajarao; Jason K Taylor; Michael W Steffes; Abdullah K Salahudeen; Michael F Flessner; Ermeg L Akylbekova; Caroline S Fox; Robert J Garrison; Herman A Taylor Journal: BMC Nephrol Date: 2010-01-15 Impact factor: 2.388